HHS will require health care plans to use pharmacy and therapeutics (P&T) committees to ensure that their formulary lists sufficiently cover prescription drugs, while keeping the current drug count standard and classification system, according to CMS' final rule on 2016 benefit and payment parameters released Feb. 20. “We believe that a combination of a qualitative and quantitative approach will best ensure robust formulary design, because the two standards can complement each other,” the final rule states. The requirement that the...